131 related articles for article (PubMed ID: 18334523)
1. Inhibition of osteoclasts does not prevent joint ankylosis in a mouse model of spondyloarthritis.
Lories RJ; Derese I; Luyten FP
Rheumatology (Oxford); 2008 May; 47(5):605-8. PubMed ID: 18334523
[TBL] [Abstract][Full Text] [Related]
2. Addition of bisphosphonate to antibiotic and anti-inflammatory treatment reduces bone resorption in experimental Staphylococcus aureus-induced arthritis.
Verdrengh M; Carlsten H; Ohlsson C; Tarkowski A
J Orthop Res; 2007 Mar; 25(3):304-10. PubMed ID: 17089391
[TBL] [Abstract][Full Text] [Related]
3. Bolus or weekly zoledronic acid administration does not delay endochondral fracture repair but weekly dosing enhances delays in hard callus remodeling.
McDonald MM; Dulai S; Godfrey C; Amanat N; Sztynda T; Little DG
Bone; 2008 Oct; 43(4):653-62. PubMed ID: 18582604
[TBL] [Abstract][Full Text] [Related]
4. Fcgamma receptors directly mediate cartilage, but not bone, destruction in murine antigen-induced arthritis: uncoupling of cartilage damage from bone erosion and joint inflammation.
van Lent PL; Grevers L; Lubberts E; de Vries TJ; Nabbe KC; Verbeek S; Oppers B; Sloetjes A; Blom AB; van den Berg WB
Arthritis Rheum; 2006 Dec; 54(12):3868-77. PubMed ID: 17133594
[TBL] [Abstract][Full Text] [Related]
5. Articular damage is associated with intraosseous inflammation in the subchondral bone marrow of joints affected by experimental inflammatory arthritis and is modified by zoledronate treatment.
Bogoch ER; Lee TC; Fornasier VL; Berger SA
J Rheumatol; 2007 Jun; 34(6):1229-40. PubMed ID: 17516617
[TBL] [Abstract][Full Text] [Related]
6. Evidence for uncoupling of inflammation and joint remodeling in a mouse model of spondylarthritis.
Lories RJ; Derese I; de Bari C; Luyten FP
Arthritis Rheum; 2007 Feb; 56(2):489-97. PubMed ID: 17265484
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of inflammation but not ankylosis by glucocorticoids in mice: further evidence for the entheseal stress hypothesis.
Braem K; Deroose CM; Luyten FP; Lories RJ
Arthritis Res Ther; 2012 Mar; 14(2):R59. PubMed ID: 22410100
[TBL] [Abstract][Full Text] [Related]
8. T lymphocytes are not required for the spontaneous development of entheseal ossification leading to marginal ankylosis in the DBA/1 mouse.
Corthay A; Hansson AS; Holmdahl R
Arthritis Rheum; 2000 Apr; 43(4):844-51. PubMed ID: 10765929
[TBL] [Abstract][Full Text] [Related]
9. Concurrent administration of zoledronic acid and irradiation leads to improved bone density, biomechanical strength, and microarchitecture in a mouse model of tumor-induced osteolysis.
Arrington SA; Damron TA; Mann KA; Allen MJ
J Surg Oncol; 2008 Mar; 97(3):284-90. PubMed ID: 18161868
[TBL] [Abstract][Full Text] [Related]
10. Ankylosing enthesitis, dactylitis, and onychoperiostitis in male DBA/1 mice: a model of psoriatic arthritis.
Lories RJ; Matthys P; de Vlam K; Derese I; Luyten FP
Ann Rheum Dis; 2004 May; 63(5):595-8. PubMed ID: 15082495
[TBL] [Abstract][Full Text] [Related]
11. Zoledronic acid protects against local and systemic bone loss in tumor necrosis factor-mediated arthritis.
Herrak P; Görtz B; Hayer S; Redlich K; Reiter E; Gasser J; Bergmeister H; Kollias G; Smolen JS; Schett G
Arthritis Rheum; 2004 Jul; 50(7):2327-37. PubMed ID: 15248234
[TBL] [Abstract][Full Text] [Related]
12. Differential effect of doxorubicin and zoledronic acid on intraosseous versus extraosseous breast tumor growth in vivo.
Ottewell PD; Deux B; Mönkkönen H; Cross S; Coleman RE; Clezardin P; Holen I
Clin Cancer Res; 2008 Jul; 14(14):4658-66. PubMed ID: 18628481
[TBL] [Abstract][Full Text] [Related]
13. Tenosynovitis and osteoclast formation as the initial preclinical changes in a murine model of inflammatory arthritis.
Hayer S; Redlich K; Korb A; Hermann S; Smolen J; Schett G
Arthritis Rheum; 2007 Jan; 56(1):79-88. PubMed ID: 17195210
[TBL] [Abstract][Full Text] [Related]
14. Cathepsin K deficiency partially inhibits, but does not prevent, bone destruction in human tumor necrosis factor-transgenic mice.
Schurigt U; Hummel KM; Petrow PK; Gajda M; Stöckigt R; Middel P; Zwerina J; Janik T; Bernhardt R; Schüler S; Scharnweber D; Beckmann F; Saftig P; Kollias G; Schett G; Wiederanders B; Bräuer R
Arthritis Rheum; 2008 Feb; 58(2):422-34. PubMed ID: 18240253
[TBL] [Abstract][Full Text] [Related]
15. Ankylosis of hock joints in group caged male B6C3F1 mice.
Rao GN; Lindsey JR
Lab Anim Sci; 1988 Aug; 38(4):417-21. PubMed ID: 3184849
[TBL] [Abstract][Full Text] [Related]
16. Synergistic inhibitory activity of zoledronate and paclitaxel on bone metastasis in nude mice.
Lu S; Zhang J; Zhou Z; Liao ML; He WZ; Zhou XY; Li ZM; Xiang JQ; Wang JJ; Chen HQ
Oncol Rep; 2008 Sep; 20(3):581-7. PubMed ID: 18695909
[TBL] [Abstract][Full Text] [Related]
17. Targeting osteoclasts with zoledronic acid prevents bone destruction in collagen-induced arthritis.
Sims NA; Green JR; Glatt M; Schlict S; Martin TJ; Gillespie MT; Romas E
Arthritis Rheum; 2004 Jul; 50(7):2338-46. PubMed ID: 15248235
[TBL] [Abstract][Full Text] [Related]
18. Suppression of inflammation and structural damage in experimental arthritis through molecular targeted therapy with PPI-2458.
Hannig G; Bernier SG; Hoyt JG; Doyle B; Clark E; Karp RM; Lorusso J; Westlin WF
Arthritis Rheum; 2007 Mar; 56(3):850-60. PubMed ID: 17328059
[TBL] [Abstract][Full Text] [Related]
19. Treatment with N-tosyl-l-phenylalanine chloromethyl ketone after the onset of collagen-induced arthritis reduces joint erosion and NF-kappaB activation.
Choi J; Ha KH; Byun MS; Min SY; Park MJ; Park HS; Oh HJ; Ju JH; Kim HY; Jue DM
Eur J Pharmacol; 2008 Oct; 595(1-3):108-13. PubMed ID: 18706406
[TBL] [Abstract][Full Text] [Related]
20. A phosphorus-based dendrimer targets inflammation and osteoclastogenesis in experimental arthritis.
Hayder M; Poupot M; Baron M; Nigon D; Turrin CO; Caminade AM; Majoral JP; Eisenberg RA; Fournié JJ; Cantagrel A; Poupot R; Davignon JL
Sci Transl Med; 2011 May; 3(81):81ra35. PubMed ID: 21543721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
